AstraZeneca News Monitoring

Astrazeneca Calquence granted priority review by USFDA for previously untreated mantle cell lymphoma

Cambridge: AstraZeneca's supplemental New Drug Application (sNDA) for Calquence (acalabrutinib) has been accepted and granted Priority Review in the US for the treatment of adult patients with previously untreated mantle cell lymphoma (MCL). The Food …

What Can Science Do? AstraZeneca Campaign Has The Answers

In 2017, viewers of the pilot episode of Hulu’s “The Handmaid’s Tale” found themselves identifying to an excruciating degree with the agonies of the title character, played by Elizabeth Moss, as “Offred” copes with the terrors of a post-democracy U.S. Reed …

Novo Nordisk/AstraZeneca's Manufacturing Partner Thermo Fisher Questioned Over Manufacturing Lapses

Thermo Fisher Scientific’s TMO one of the largest contract drug manufacturing sites in the U.S., has repeatedly been flagged for regulatory violations. Thermo Fisher’s Greenville facility manufactures around 40 medicines, including Novo Nordisk A/S’ …

FDA grants priority review for AstraZeneca’s Calquence sNDA

The US Food and Drug Administration (FDA) has accepted and granted priority review to AstraZeneca's supplemental New Drug Application (sNDA) for Calquence (acalabrutinib) for the treatment of adult patients with previously untreated mantle cell …

‘Fit and healthy’ Jason, 51, died 16 days after AstraZeneca Covid jab

A 'fit and healthy' 51-year-old man died 'as a consequence' of having a Covid jab. Jason Eagles, of Bucknall, died 16 days after receiving his first AstraZeneca Covid jab on February 25, 2021. A Stoke inquest has heard Jason developed a …

US FDA accepts and grants priority review status to AstraZeneca's sNDA for Calquence to treat patients with untreated ...

AstraZeneca’s supplemental New Drug Application (sNDA) for Calquence (acalabrutinib) has been accepted and granted Priority Review in the US for the treatment of adult patients with previously untreated mantle cell lymphoma (MCL). The Food and Drug …

Arcus and AstraZeneca Enter Collaboration for Clinical Trial in Renal Cell Carcinoma

Arcus Biosciences has announced a clinical trial collaboration agreement with AstraZeneca to evaluate casdatifan (AB521), Arcus’s investigational HIF-2a inhibitor, alongside volrustomig, AstraZeneca’s investigational PD-1/CTLA-4 bispecific antibody in …

AstraZeneca Seeks Expanded Use For Blood Cancer Drug Calquence, FDA Grants Priority Review

On Thursday, the FDA accepted and granted Priority Review to AstraZeneca Plc’s AZN supplemental marketing application for Calquence (acalabrutinib) for adult patients with previously untreated mantle cell lymphoma (MCL). The Prescription Drug User Fee Act …

Arcus and AstraZeneca enter trial collaboration for renal cancer treatment

Arcus Biosciences has announced a clinical trial partnership with AstraZeneca to assess the combination of casdatifan (AB521) and volrustomig in patients with clear cell renal cell carcinoma (ccRCC). Casdatifan is an investigational HIF-2a inhibitor of …

Owkin and AstraZeneca to develop AI tool for breast cancer testing

Owkin has announced a partnership with AstraZeneca to create an AI gBRCA pre-screening solution designed to identify mutations in breast cancer patients from pathology slides. This tool, part of the PortrAIt consortium with Gustave Roussy and The Centre …

New androgen receptor degradation inducers disclosed in Astrazeneca patent

This week in R&D: Slight increase in global economic growth expected in 2024, Korean chipmakers visit UAE, and ...

The R&D World Index (RDWI) for the week ending September 27, 2024, closed at 3,980.69 for the 25 companies in the RDWI. The Index was down -0.66% (or -26.26 basis points). Thirteen RDWI members gained value last week from 0.03% (Sanofi SA) to 20.30% ( …

US FDA grants priority review status to AstraZeneca & Daiichi Sankyo's sBLA for Enhertu for patients with HER2─low or ...

AstraZeneca and Daiichi Sankyo’s supplemental Biologics License Application (sBLA) for Enhertu (trastuzumab deruxtecan) has been accepted and granted Priority Review in the US for the treatment of adult patients with unresectable or metastatic HER2-low ( …

Rupa Dainer, MD, U.S. Navy Veteran and AstraZeneca’s Medical Director, Joins Dream Foundation Board

Press releases are posted on Independent.com as a free community service. Santa Barbara, Calif.– 2024 October 2 –Rupa Dainer, MD, U.S. Navy veteran and medical director, senior patient safety physician of AstraZeneca, has joined the Board of Directors of …

Owkin, AstraZeneca partner to develop an AI gBRCA prescreen remedy for breast cancer

AI biotech company Owkin announced a partnership with pharma giant AstraZeneca to develop an AI-powered tool designed to prescreen for gBRCA mutations (gBRCAm) in breast cancer directly from digitized pathology slides. According to Owkin, BRCA testing, …

USFDA grants priority review to AstraZeneca-Daiichi Sankyo Enhertu for HER2-low, HER2 Ultralow Breast Cancer

AstraZeneca and Daiichi Sankyo's supplemental Biologics License Application (sBLA) for Enhertu (trastuzumab deruxtecan) has been accepted and granted Priority Review in the US for the treatment of adult patients with unresectable or metastatic HER2-low …

Owkin, Astrazeneca developing AI-powered breast cancer test

Owkin Partners with AstraZeneca for Advanced AI gBRCA Pre-Screening

Share Tweet Share Share Email Owkin has partnered with AstraZeneca to develop an AI gBRCA pre-screen solution for breast cancer. Takeaway Points Owkin has partnered with AstraZeneca to develop an AI gBRCA pre-screen solution for breast cancer. BRCA testing …

AstraZeneca, AbbVie, PhRMA lose court battle over Louisiana 340B law

FOR IMMEDIATE RELEASE: How Social Media Is Empowering Women To Fight Back Against The Gender Health Gap

Women's health issues have often been overlooked, but social media is now empowering women by raising awareness and advocating for better healthcare. LONDON, LONDON, UNITED KINGDOM, October 7, 2024 /⁨EINPresswire.com⁩/ -- Women's health …

The Ins and Outs of Deducting Child Care Expenses on Taxes in 2024 and 2025 Announced by Harbor Financial

The question on everyone's mind is: Can child care expenses be deducted on taxes? TRAVERSE CITY, MI, UNITED STATES, October 6, 2024 /⁨EINPresswire.com⁩/ -- As tax season is in full swing, many working parents are wondering about the tax …

EMPERRA® submitted the Digital Diabetes Management Platform ESYSTA® for approval as DiGA (DTx) to the German BfArM

Emperra has submitted ESYSTA for permanent listing as a Digital Health Application (DTx) to the Federal Institute for Drugs and Medical Devices (BfArM Germany) POTSDAM, BRANDENBURG, GERMANY, October 6, 2024 /⁨EINPresswire.com⁩/ -- EMPERRA® E- …

Bio Pharma Buffer Market to Reach $2.4 Billion, Globally, by 2033 at 7.8% CAGR: Allied Market Research

Wilmington, Delaware, Oct. 06, 2024 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Bio Pharma Buffer Market by Buffer Type (Phosphates Type, Acetates Type, Tris Type and Others), by Application (Protein Purification, Cell …

Karns & Karns Personal Injury and Accident Attorneys Expands to Temecula, Giving Top-Tier Legal Help to Accident Victims

Karns & Karns Personal Injury and Accident Attorneys introduces their expert legal services to Temecula, enhancing support for local accident victims TEMECULA, CA, UNITED STATES, October 6, 2024 /⁨EINPresswire.com⁩/ -- Karns & Karns …

Understanding Medicare Deductions from Social Security Benefits in 2024 & 2025

As individuals approach retirement age, understanding the various deductions from Social Security benefits becomes crucial. One such deduction is for Medicare. TRAVERSE CITY, MI, UNITED STATES, October 5, 2024 /⁨EINPresswire.com⁩/ -- As …

SmileFy Unveils Integration with DEXIS™ Intraoral Scanners to Enhance Digital Dental Workflows

FORT LAUDERDALE, FL, UNITED STATES, October 5, 2024 /⁨EINPresswire.com⁩/ -- SmileFy, renowned for its cutting-edge AI-driven 3D digital smile design solutions, is thrilled to announce its seamless integration with DEXIS™ intraoral scanners, setting …

Ninth Annual NAMIWalks Silicon Valley Takes Place This Saturday in History Park

Annual event benefits NAMI Santa Clara County’s mental health programs SAN JOSE, CA, UNITED STATES, October 5, 2024 /⁨EINPresswire.com⁩/ -- The local affiliate of the National Alliance on Mental Illness, NAMI Santa Clara County, will hold its …

Sabin Vaccine Institute Delivers Marburg Vaccines to Combat Outbreak in Rwanda

[Caption] Sabin Vaccine Institute delivered 700 doses of its Marburg vaccine to Rwanda on Oct. 5, 2024. WASHINGTON, Oct. 05, 2024 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute has provided its investigational Marburg vaccine to Rwanda to support the …

NHS rolls out free eyesight, hearing and dental checks for children at residential special schools

Children and young people with special educational needs and disabilities in residential special schools and colleges across England are to be offered free NHS eyesight, hearing and dental checks. Autistic children and young people and those with a …

Karns & Karns Personal Injury and Accident Attorneys Expand Inland Empire Presence with New Riverside Office

Karns & Karns Personal Injury Attorneys Launch Riverside Office, Bringing Dedicated Legal Advocacy to Accident Victims RIVERSIDE, CA, UNITED STATES, October 4, 2024 /⁨EINPresswire.com⁩/ -- Karns & Karns Personal Injury and Accident …

Karns & Karns Personal Injury and Accident Attorneys Expands Southern California Presence with New Santa Monica Office

Karns & Karns Personal Injury and Accident Attorneys Opens New Santa Monica Office, Strengthening Commitment to Accident Victims SANTA MONICA, CA, UNITED STATES, October 4, 2024 /⁨EINPresswire.com⁩/ -- Karns & Karns Personal Injury and …

Nueva Perspectiva en Estética Facial: El Enfoque Personalizado del Dr. Simon Ourian en Epione Beverly Hills

El Dr. Ourian de Epione cree en tratamientos personalizados a través de conversaciones significativas, logrando resultados que se adapten a tu belleza única BEVERLY HILLS, CA, UNITED STATES, October 4, 2024 /⁨EINPresswire.com⁩/ -- Dr. Simon Ourian …

Optical Brightener Market Growth Analysis with Investment Opportunities For 2024-2033

Optical Brightener Global Market Report 2024 – Market Size, Trends, And Forecast 2024-2033 LONDON, GREATER LONDON, UNITED KINGDOM, October 4, 2024 /⁨EINPresswire.com⁩/ -- The optical brightener market has experienced robust growth in recent …

Non-Steroidal Anti-inflammatory Drugs Market Size, Share, Revenue, Trends, and Drivers For 2024-2033

The Business Research Company’s Non-Steroidal Anti-inflammatory Drugs Global Market Report 2024 – Market Size, Trends, And Market Forecast 2024-2033 LONDON, GREATER LONDON, UNITED KINGDOM, October 4, 2024 /⁨EINPresswire.com⁩/ -- The non-steroidal …

Global Liver Diseases Therapeutics Market Size, Share, And Growth Analysis For 2024-2033

The Business Research Company's Liver Diseases Therapeutics Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033 LONDON, GREATER LONDON, UNITED KINGDOM, October 4, 2024 /⁨EINPresswire.com⁩/ -- The liver diseases …

Medical Gas And Equipment Market Size, Share, Revenue, Trends And Drivers For 2024-2033

The Business Research Company's Medical Gas And Equipment Market Size, Share, Revenue, Trends And Drivers For 2024-2033 LONDON, GREATER LONDON, UNITED KINGDOM, October 4, 2024 /⁨EINPresswire.com⁩/ -- The medical gas and equipment market has …

Medical Ceramics Market Segments, Drivers, Restraints, And Trends For 2024-2033

The Business Research Company's Medical Ceramics Market Segments, Drivers, Restraints, And Trends For 2024-2033 LONDON, GREATER LONDON, UNITED KINGDOM, October 4, 2024 /⁨EINPresswire.com⁩/ -- The medical ceramics market has experienced robust …

Medical Bionic Implant/Artificial Organs Market Size, Share, Revenue, Trends, and Drivers For 2024-2033

The Business Research Company's Medical Bionic Implant/Artificial Organs Market Size, Share, Revenue, Trends, and Drivers For 2024-2033 LONDON, GREATER LONDON, UNITED KINGDOM, October 4, 2024 /⁨EINPresswire.com⁩/ -- The medical bionic …

Muscle Relaxant Drugs Global Market 2024 To Reach $6.55 Billion By 2028 At Rate Of 7.9%

The Business Research Company’s Muscle Relaxant Drugs Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033 LONDON, GREATER LONDON, UNITED KINGDOM, October 4, 2024 /⁨EINPresswire.com⁩/ -- The muscle relaxant drugs market …